Peripheral Neuropathy and Vitamin B12

From a Western clinical lens, the relationship between vitamin B12 and peripheral neuropathy is mechanistically direct and clinically actionable. Cobalamin is required for methionine synthase and methylmalonyl‑CoA mutase—enzymes central to methylation capacity and fatty acid metabolism. When B12 is insufficient, homocysteine and methylmalonic acid accumulate, myelin maintenance falters, and distal sensory axons are particularly vulnerable. The typical presentation is a bilateral, length‑dependent sensory neuropathy with numbness, paresthesia, burning pain, and loss of vibration and proprioception; severe cases may extend to the spinal cord, producing gait ataxia and weakness. Diagnosis begins with history and examination, emphasizing diet, gastrointestinal surgery, autoimmune risk, medications (metformin, proton‑pump inhibitors), and nitrous oxide exposure. Serum B12 is a reasonable first test, but normal or low‑normal values can mask tissue deficiency; MMA and homocysteine improve diagnostic sensitivity. Macrocytosis on CBC and intrinsic‑factor/parietal cell antibodies suggest pernicious anemia. EMG/NCS and neurology referral are reserved for red flags—rapid progression, prominent motor involvement, marked asymmetry, or poor response to repletion—where alternative etiologies like CIDP, toxic, or compressive neuropathies must be excluded. Treatment centers on B12 repletion, either high‑dose oral or intramuscular, with monitoring of symptoms and biochemical markers. Evidence supports clinical improvement in neuropathic symptoms when deficiency is promptly corrected; however, the duration and severity of deficiency predict reversibility, and some patients have residual numbness or gait imbalance despite normalized labs. If pain persists, guideline‑supported agents (duloxetine, gabapentin/pregabalin, certain tricyclics) and topical lidocaine or capsaicin may be added. Fall‑prevention strategies and physical therapy help compensate for sensory loss. Prevention focuses on identifying at‑risk groups—older adults with atrophic gastritis, vegans without fortified foods, patients after bariatric surgery, and those on long‑term metformin or acid suppression—and ensuring reliable B12 sources or supplementation. Addressing causative factors (e.g., avoiding nitrous oxide misuse, reassessing chronic PPI use) reduces recurrence.

Traditional systems frame neuropathy through functional patterns rather than isolated nutrient deficits, yet their emphasis on nourishment and circulation aligns conceptually with modern B12 physiology. In Ayurveda, distal numbness and burning are expressions of aggravated Vata with depletion of nerve tissue (majja dhatu). Care aims to restore stability and lubrication via warm, grounding foods, oil therapies (abhyanga), and rasayana (rejuvenative) measures. For those avoiding animal products, modern integrative practitioners incorporate fortified foods or B12 supplementation alongside Ayurvedic diet to ensure biochemical sufficiency while honoring dietary ethics. Gentle yoga, pranayama, and adequate sleep are used to calm sensory hypersensitivity and support balance. Traditional Chinese Medicine interprets peripheral neuropathy as obstruction or deficiency within the channels—often a mix of qi and blood deficiency with damp or cold stagnation in the lower limbs. Acupuncture and moxibustion seek to restore flow, improve microcirculation, and modulate pain pathways. Contemporary clinical studies suggest acupuncture can reduce neuropathic symptoms for some patients, though heterogeneity and methodological limits temper certainty. In East Asian biomedicine, methylcobalamin is widely used as a neurotrophic agent, reflecting a pragmatic integration of traditional and modern methods; small trials suggest symptomatic benefit in diabetic neuropathy, especially when combined with lifestyle and glycemic measures. Across traditions, the most coherent integrative approach pairs assured B12 adequacy (through diet or supplements) with symptomatic modalities—acupuncture, mindful movement, massage—that may enhance comfort and function. Collaboration with biomedical clinicians ensures that red‑flag features are not missed and that persistent pain is managed with evidence‑based pharmacologic and nonpharmacologic options.